Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure - Wikidata - wikimedia - TriplyDB

Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure

Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure

http://www.wikidata.org/entity/Q35393885

about

The current status of heart failure diagnostic biomarkers.ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.Cancer antigen-125 and outcomes in acute heart failure: a systematic review and meta-analysis

P2860

Q38703882-427C1B7B-9CF5-45EA-8025-E61E1D42D5D5 Q41083010-20F91C11-68A7-492F-AAF3-968515734483 Q58542927-8B99699A-8D15-41C9-944B-8316EAB59E07

P2860

Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure

http://www.wikidata.org/entity/Q35393885

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prognostic value of the intera ...... ate 125 in acute heart failure

@ast

Prognostic value of the intera ...... ate 125 in acute heart failure

@en

type

label

Prognostic value of the intera ...... ate 125 in acute heart failure

@ast

Prognostic value of the intera ...... ate 125 in acute heart failure

@en

prefLabel

Prognostic value of the intera ...... ate 125 in acute heart failure

@ast

Prognostic value of the intera ...... ate 125 in acute heart failure

@en

P1433

Q35393885-94A31500-C270-405D-A176-B95ED3A17998

P1476

Q35393885-AEB8EF7A-59E5-4514-9ED3-A8EFDA255194

P2093

Q35393885-0036CC7F-F83A-4207-A3DE-3A21FE425228

Q35393885-059AE1EE-96D2-42EE-8662-06F58C128C8E

Q35393885-233EAEC8-9E75-4A7A-8C83-59E7B2989F6D

Q35393885-77AB16E6-2F5F-4E0E-855D-6EEA4315F87C

Q35393885-7D17C92A-9504-490E-8711-397297EBE2E4

Q35393885-9A488921-5CBD-4E9F-9326-CCC916A8381E

Q35393885-BF421240-04F1-41C5-A483-D125940D9F6C

Q35393885-C3F2F2B1-B0FE-4BEB-A880-FC964B1B75BD

Q35393885-C58D054A-763D-4DC7-8320-D18C2AC9E5B2

Q35393885-DFA5EE74-75B1-4C7B-A43B-4E3409818EEE

P2860

Q35393885-18E4FF52-3C96-4DA5-A4D5-4EAF4DA66F82

Q35393885-1D4BD69B-C978-4048-A79E-DD325B013154

Q35393885-22BDE343-E94C-40B5-B93E-E1E37C1AC111

Q35393885-29A943B8-AAB2-4648-97E6-524BE484177D

Q35393885-3DC21A75-79DB-41CC-AB2E-80D95A252DEC

Q35393885-3FC8BDEC-D05D-4975-9FF9-3ECF886255D3

Q35393885-4EA53AED-C4B7-49A9-9AAD-5E47ABF05111

Q35393885-5217DF39-CCD9-422B-9CEE-9120F9F57384

Q35393885-60E4793D-0C65-47C7-912D-F7395DB35F86

Q35393885-61DDE2C4-52E4-4444-8E93-594AAF6D818F

P304

Q35393885-7F35CAE2-A7C6-4E63-BD48-1D0F41EB05E8

P31

Q35393885-B4ABBFA1-A463-43FF-B839-1043BC0EB580

P356

Q35393885-8537F3C6-D9A2-4E5E-9C86-E79653D4B714

P407

Q35393885-22EE84DD-DF22-43B8-9DC4-5FBE4BA23037

P433

Q35393885-C61C8A1C-1210-482D-9141-A9194D93786E

P478

Q35393885-8748CA7F-34C9-44F5-8890-36B1FA2BA1B4

P50

Q35393885-3D13E292-4C46-484F-8AB0-F5B55392D8B0

Q35393885-BF51C8BE-8226-4A6F-8FDD-583B674BAC3C

P577

Q35393885-354DB8E3-C38D-4D23-B3A8-92B4D9EE13E7

P5875

Q35393885-2E69E179-F30C-40FC-B15C-ECD947399F23

P698

Q35393885-92AF8504-994D-47F3-B8FD-E22C3085E2CD

P932

Q35393885-6B9DB40E-09B8-4C65-974D-5F8A488019E3

P356

JOURNAL.PONE.0122360

P1433

P1476

Prognostic value of the intera ...... ate 125 in acute heart failure

@en

P2093

Eduardo Núñez

http://www.w3.org/2001/XMLSchema#string

Enrique Santas

http://www.w3.org/2001/XMLSchema#string

Francisco J Chorro

http://www.w3.org/2001/XMLSchema#string

Gabriel A Rabinovich

http://www.w3.org/2001/XMLSchema#string

Gema Miñana

http://www.w3.org/2001/XMLSchema#string

Juan Sanchis

http://www.w3.org/2001/XMLSchema#string

Justo Sandino

http://www.w3.org/2001/XMLSchema#string

Luis Mainar

http://www.w3.org/2001/XMLSchema#string

Maria Pilar Villanueva

http://www.w3.org/2001/XMLSchema#string

Vicent Bodí

http://www.w3.org/2001/XMLSchema#string

P2860

Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier

Galectin-3 in angiogenesis and metastasis.

Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling.

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

The cancer antigen CA125 represents a novel counter receptor for galectin-1.

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

P304

e0122360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0122360

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275235221

http://www.w3.org/2001/XMLSchema#string

P698

25875367

http://www.w3.org/2001/XMLSchema#string

P932

4395409

http://www.w3.org/2001/XMLSchema#string